6053-96-9

Upstream product

• 93-03-8 (3,4-dimethoxyphenyl)methanol 
• 2173-23-1 2-(3,4-dimethoxybenzyloxy)isoindole-1,3-dione 

Downstream Products

• 812652-61-2 5-benzhydryl-3-(3,4-dimethoxybenzyloxy)-4-imino-oxazolidin-2-one 
• 1299491-43-2 4,5-dibromo-1H-pyrrole-2-carboxylic acid (3,4-dimethoxybenzyloxy)amide 
• 1446945-89-6 C₂₀H₂₇N₃O₅ 
• 1446946-28-6 7-[3-amino-4-(3',4'-dimethoxybenzyloxyimino)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 1446946-15-1 C₁₉H₂₉N₃O₅ 
• 1446946-02-6 C₂₀H₂₉N₃O₆ 
• 930281-05-3 N-(3,4-dimethoxy-benzyloxy)-propionamide 
• 1176952-61-6 N-(3,4-dimethoxy-benzyloxy)-2-phenyl-acetamide 
• 930281-03-1 N-(3,4-dimethoxy-benzyloxy)-benzamide 
• 1176952-55-8 naphtahlene-1-carboxylic acid (3,4-dimethoxy-benzyloxy)-amide 
• 1176952-52-5 N-(3,4-dimethoxybenzyloxy)furan-2-carboxamide 
• 827585-06-8 7-(5-adamantan-1-yl-3-methyl-pent-2-enyl)-1,7-dihydro-purin-6-one O-(3,4-dimethoxy-benzyl)-oxime 
• 827585-36-4 7-(3-methyl-but-2-enyl)-1,7-dihydro-purin-6-one O-(3,4-dimethoxy-benzyl)-oxime 
• 827585-45-5 7,8,9,10-tetrahydro-10-(3,4-dimethoxybenzyloxy)-9,9-dimethyl[1,4]diazepino[1,2,3-g,h]purine 

Relevant academic research and scientific papers

Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety

A series of novel IMB-070593 derivatives containing a substituted benzyloxime moiety and displaying a remarkable improvement in lipophilicity were synthesized and evaluated for their in vitro antimycobacterial and antibacterial activity. Our results reveal that the target compounds 19a-m have considerable Gram-positive activity (MIC: 0.008-32 μg/mL), although they are generally less active than the reference drugs against the Gram-negative strains. In particular, compounds 19h, 19j, 19k and 19m show good activity (MICs: 0.008-4 μg/mL) against all of the tested Gram-positive strains, including ciprofloxacin (CPFX)- and/or levofloxacin (LVFX)-resistant MSSA, MRSA and MSSE. Moreover, compound 19l (MIC: 0.125 μg/mL) is found to be 2-4 fold more active than the parent IMB070593, CPFX and LVFX against M. tuberculosis H37Rv ATCC 27294.

Design, synthesis and antifungal activities of novel pyrrole alkaloid analogs

A series of novel analogs of pyrrole alkaloid were designed and synthesized by a facile method and their structures were characterized by 1H NMR, 13C NMR and high-resolution mass spectrometry (HRMS). The structure of compound 2a was identified by 2D NMR including heteronuclear multiple-quantum coherence (HMQC), heteronuclear multiple-bond correlation (HMBC) and H-H correlation spectrometry (H-H COSY) spectra. Their antifungal activities against five fungi were evaluated, and the results indicated that some of the title compounds showed moderate fungicidal activities in vitro against Alternaria solani, Cercospora arachidicola, Fusarium omysporum, Gibberella zeae and Physalospora piricola at the dosage of 50 μg mL -1. Compound 2a and 3a exhibited good activities against P. piricola at low dosage.